Composition containing buffer
Provided is a composition containing a buffer to be used at the time of labeling of a chelated targeting agent with 90 Y, 153 Sm, 165 Dy, 165 Er, 166 Ho, or 177 Lu. At least one kind of buffer selected from the group consisting of benzoic acid, maleic acid, fumaric acid, succinic acid, and salts thereof is incorporated in a composition containing a chelated targeting agent.
1. A method of producing a radioactive metal-labeled chelated targeting agent, the method comprising:
adding a radioactive metal selected from the group consisting of 90 Y, 153 Sm, 165 Dy, 165 Er, 166 Ho, and 177 Lu to a mixture of a chelated targeting agent selected from the group consisting of a low-molecular-weight compound, a peptide, a protein, an antibody, an antibody fragment, and a nucleic acid chelated with at least one member selected from the group consisting of
and at least one buffer selected from the group consisting of benzoic acid, maleic acid, and salts thereof to form a complex between the radioactive metal and the chelated targeting agent,
wherein a pH of a reaction liquid at the time of labelling of the chelated targeting agent with the radioactive metal is adjusted to fall within a range of the pKa value of the buffer plus or minus 1.5.
2. A method of producing a radioactive metal-labeled chelated targeting agent, the method comprising:
adding a radioactive metal selected from the group consisting of 90 Y, 153 Sm, 165 Dy, 165 Er, 166 Ho, and 177 Lu to a mixture of a chelated targeting agent selected from the group consisting of a low-molecular-weight compound, a peptide, a protein, an antibody, an antibody fragment, and a nucleic acid chelated with at least one member selected from the group consisting of:
and at least one compound selected from the group consisting of benzoic acid, maleic acid, a conjugate base of benzoic acid, a conjugate base of maleic acid, a mixture of benzoic acid and a conjugate base of benzoic acid, and a mixture of maleic acid and a conjugate base of maleic acid, to form a complex between the radioactive metal and the chelated targeting agent,
wherein a pH of a reaction liquid at the time of labelling of the chelated targeting agent with the radioactive metal is adjusted to fall within a range of the pKa value of the compound plus or minus 1.5.
3. The method of claim 1 , wherein the radioactive metal is selected from the group consisting of 90 Y and 177 Lu.
4. The method of claim 1 , wherein the chelate group comprises a chelate group having a DOTA structure selected from the group consisting of
and the targeting moiety is an anti-CDH3 antibody.
5. The method of claim 2 , wherein the radioactive metal is selected from the group consisting of 90 Y and 177 Lu.
6. The method of claim 2 , wherein the chelate group comprises a chelate group having a DOTA structure selected from the group consisting of
and the targeting moiety is an anti-CDH3 antibody.
7. The method of claim 1 , wherein the buffer is selected from the group consisting of benzoic acid, a conjugate base of benzoic acid, a mixture of benzoic acid and a conjugate base of benzoic acid.
8. The method of claim 2 , wherein the compound is selected from the group consisting of benzoic acid, a conjugate base of benzoic acid, a mixture of benzoic acid and a conjugate base of benzoic acid.